Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
93,625,050
-
Share change
-
-3,341,754
-
Total reported value
-
$308,015,892
-
Put/Call ratio
-
247%
-
Price per share
-
$3.29
-
Number of holders
-
171
-
Value change
-
-$9,999,146
-
Number of buys
-
91
-
Number of sells
-
68
Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q2 2023
As of 30 Jun 2023,
BLUEBIRD BIO INC - COM (BLUE) was held by
171 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,625,050 shares.
The largest 10 holders included
STATE STREET CORP, BlackRock Inc., TANG CAPITAL MANAGEMENT LLC, PFM Health Sciences, LP, VANGUARD GROUP INC, Granahan Investment Management, LLC, PICTET ASSET MANAGEMENT SA, BAKER BROS. ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
171
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.